Clinical and pathological correlation of increased MYC gene copy number in diffuse large B-cell lymphoma (DLBCL)

In this study, we found no significant difference in survival between cases of DLBCL with MYC ICN and cases with no MYC aberrations (p=0.58). Teaser Comparison of cases of DLBCL with increased copy number of MYC to those without MYC aberration demonstrated no significant difference in survival (p=0.58) for patients treated with Rituximab based regimens.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research